Cart summary

You have no items in your shopping cart.

SRT2104

SKU: orb1222878

Description

SRT2104, also known as GSK2245840, is a novel, first-in-class, highly selective small molecule activator of the NAD + dependent deacetylase SIRT1. SRT2104 has been developed as a selective small molecule activator of SIRT1, a NAD(+)-dependent deacetylase involved in the regulation of energy homeostasis and the modulation of various metabolic pathways, including glucose metabolism, oxidative stress and lipid metabolism. SIRT1 has been suggested as putative therapeutic target in multiple age-related diseases including type 2 diabetes and dyslipidemias.(In Vivo):SRT 2104 (100 mg/kg/day, supplemented in diet for 24 weeks) increases SIRT1 protein without altering Sirt1 mRNA in diabetic mice.SRT 2104 (100 mg/kg/day, supplemented in diet for 24 weeks) decreases testicular oxidative stress, activation of apoptotic signaling, and ER stress in diabetic mice.SRT 2104 (0.5%; for 18 weeks) improves motor function and increases survival in N171-82Q HD mice.

Images & Validation

Key Properties

CAS Number1093403-33-8
MW516.64
Purity>98% (HPLC)
FormulaC26H24N6O2S2
SMILESCc1c(sc(n1)c1cnccc1)C(=O)Nc1ccccc1c1cn2c(csc2n1)CN1CCOCC1
TargetDNA/RNA Synthesis
SolubilityDMSO : 5 mg/mL 9.68 mM; H2O : < 0.1 mg/mL

Bioactivity

In Vivo
SRT 2104 (100 mg/kg/day, supplemented in diet for 24 weeks) increases SIRT1 protein without altering Sirt1 mRNA in diabetic mice. SRT 2104 (100 mg/kg/day, supplemented in diet for 24 weeks) decreases testicular oxidative stress, activation of apoptotic signaling, and ER stress in diabetic mice. SRT 2104 (0.5%; for 18 weeks) improves motor function and increases survival in N171-82Q HD mice. Animal model: Male C57BL/6 mice (8-week-old). Dosage: 100 mg/kg/day. Administration: Supplemented in diet for 24 weeks. Result: Enhanced SIRT1 protein without evelating Sirt1 mRNA level. Attenuated diabetes mellitus (DM)-induced oxidative stress, apoptotic signaling, and ER stress. Animal model: WT and N171-82Q HD mice (6 weeks old). Dosage: 0.5%. Administration: 0.5% SRT 2104 containing diet for 6, 12, 18 weeks. Result: Ameliorated motor deficits and increased survival in N171-82Q HD mice.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

SRT2104 | SRT 2104 | SRT-2104 | GSK2245840

Similar Products

  • SRT 2104 [orb1300562]

    99.83%

    1093403-33-8

    516.64

    C26H24N6O2S2

    1 mg, 5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

SRT2104 (orb1222878)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 150.00
10 mg
$ 200.00
25 mg
$ 340.00
50 mg
$ 540.00
100 mg
$ 790.00
200 mg
$ 1,110.00
500 mg
$ 1,680.00
1 g
$ 2,240.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry